Overview of causality assessment in drug-induced liver injury.
作者信息
Hayashi Paul H
机构信息
Division of Gastroenterology and Hepatology University of North Carolina School of Medicine Chapel Hill NC.
出版信息
Clin Liver Dis (Hoboken). 2017 Mar 1;9(2):29-33. doi: 10.1002/cld.615. eCollection 2017 Feb.
Abstract
摘要
相似文献
1
Overview of causality assessment in drug-induced liver injury.药物性肝损伤因果关系评估概述。
Clin Liver Dis (Hoboken). 2017 Mar 1;9(2):29-33. doi: 10.1002/cld.615. eCollection 2017 Feb.
2
Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.单核细胞来源的肝细胞样细胞用于评估药物所致肝损伤的体质性因果关系。
Gut. 2016 Sep;65(9):1555-63. doi: 10.1136/gutjnl-2015-309528. Epub 2015 Jun 4.
3
Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases.亚洲草药性肝损伤及RUCAM在11160例已发表病例因果关系评估中的当前作用
J Clin Transl Hepatol. 2020 Jun 28;8(2):200-214. doi: 10.14218/JCTH.2020.00009. Epub 2020 Apr 24.
4
Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.药物性肝毒性的因果关系评估：前景与陷阱
Clin Liver Dis. 2007 Aug;11(3):477-505, v. doi: 10.1016/j.cld.2007.06.003.
5
Causality assessment for suspected DILI during clinical phases of drug development.药物研发临床阶段疑似药物性肝损伤的因果关系评估。
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S47-56. doi: 10.1007/s40264-014-0185-4.
6
An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.一种用于在电子病历数据中检测药物性肝损伤的自动化因果关系评估算法。
Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):601-8. doi: 10.1002/pds.3531. Epub 2013 Oct 21.
7
Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.用于药物性肝损伤因果关系评估的Naranjo药物不良反应概率量表评价
Aliment Pharmacol Ther. 2008 May;27(9):780-9. doi: 10.1111/j.1365-2036.2008.03655.x. Epub 2008 Feb 18.
8
Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment.哥伦比亚某大学医院药物性肝损伤的流行病学：前瞻性因果评估中使用更新的 RUCAM。
Ann Hepatol. 2019 May-Jun;18(3):501-507. doi: 10.1016/j.aohep.2018.11.008. Epub 2019 Apr 18.
9
Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).使用罗塞尔·优克福因果关系评估方法（RUCAM）评估的可能与美金刚相关的肝损伤。
ACG Case Rep J. 2019 Aug 27;6(8):e00184. doi: 10.14309/crj.0000000000000184. eCollection 2019 Aug.
10
Tools for causality assessment in drug-induced liver disease.药物性肝损伤因果关系评估工具。
Curr Opin Gastroenterol. 2019 May;35(3):183-190. doi: 10.1097/MOG.0000000000000526.
引用本文的文献
1
Methimazole-induced cholestasis initially obscured by an incidental finding of a large periampullary diverticulum: A case report with reference to the updated RUCAM of 2016.甲巯咪唑诱发的胆汁淤积最初因偶然发现的一个大的壶腹周围憩室而被掩盖：一份参考2016年更新版RUCAM的病例报告
JGH Open. 2025 Feb 24;9(2):e13042. doi: 10.1002/jgh3.13042. eCollection 2025 Feb.
2
Acute liver injury in pregnancy.妊娠急性肝损伤。
BMJ Case Rep. 2024 Feb 21;17(2):e257138. doi: 10.1136/bcr-2023-257138.
3
When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.当疑似药物性肝损伤（DILI）不是 DILI 时该怎么办？来自药物性肝损伤网络的不太可能的病例分析。
Am J Gastroenterol. 2023 Dec 1;118(12):2301-2304. doi: 10.14309/ajg.0000000000002370. Epub 2023 Jun 14.
4
Tinospora cordifolia (Guduchi/Giloy)-Induced Liver Injury: A Case Review.匙羹藤（古杜奇/吉洛伊）所致肝损伤：病例回顾
Cureus. 2023 May 31;15(5):e39793. doi: 10.7759/cureus.39793. eCollection 2023 May.
5
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.药物性肝损伤（DILI）临床试验因果关系评估概述。
Drug Saf. 2021 Jun;44(6):619-634. doi: 10.1007/s40264-021-01051-5. Epub 2021 Mar 16.
6
A Rare Cause of Acute Liver Failure: Diffuse Liver Metastization of Merkel Cell Carcinoma.急性肝衰竭的罕见病因：默克尔细胞癌的弥漫性肝转移
GE Port J Gastroenterol. 2020 Apr;27(3):203-206. doi: 10.1159/000503150. Epub 2019 Oct 9.
7
Drug-induced liver injury.药物性肝损伤
Yeungnam Univ J Med. 2020 Jan;37(1):2-12. doi: 10.12701/yujm.2019.00297. Epub 2019 Aug 27.
本文引用的文献
1
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.拉美药物性肝损伤注册研究经验：一项成功的持续协作战略计划。
Int J Mol Sci. 2016 Feb 29;17(3):313. doi: 10.3390/ijms17030313.
2
Scandinavian epidemiological research in gastroenterology and hepatology.斯堪的纳维亚地区在胃肠病学和肝病学方面的流行病学研究。
Scand J Gastroenterol. 2015 Jun;50(6):636-48. doi: 10.3109/00365521.2015.1034168. Epub 2015 Apr 16.
3
Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN).药物性肝损伤网络（DILIN）中药物、草药及膳食补充剂肝毒性因果关系评估的可靠性
Liver Int. 2015 May;35(5):1623-32. doi: 10.1111/liv.12540. Epub 2014 Apr 16.
4
Causality assessment in drug-induced liver injury.药物性肝损伤的因果关系评估
Semin Liver Dis. 2009 Nov;29(4):348-56. doi: 10.1055/s-0029-1240003. Epub 2009 Oct 13.
5
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.药物性肝损伤网络（DILIN）前瞻性研究：原理、设计与实施。
Drug Saf. 2009;32(1):55-68. doi: 10.2165/00002018-200932010-00005.
6
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.鲁塞尔·优克福因果关系评估方法在药物性肝损伤因果关系评估中的可靠性。
Hepatology. 2008 Oct;48(4):1175-83. doi: 10.1002/hep.22442.
7
Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge.药物不良反应的因果关系评估——II. 验证药物因果关系评估方法的原始模型：激发试验阳性的病例报告
J Clin Epidemiol. 1993 Nov;46(11):1331-6. doi: 10.1016/0895-4356(93)90102-7.
8
Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.药物不良反应的因果关系评估——I. 一种基于国际共识会议结论的新方法：应用于药物性肝损伤
J Clin Epidemiol. 1993 Nov;46(11):1323-30. doi: 10.1016/0895-4356(93)90101-6.
Zotero 插件